UK Faces Critical Medicine Shortage Amid EU Competition

The UK is at risk of facing critical medicine shortages due to its lack of competitiveness in the generics market, as per the UK head of a leading industry player. The European Union has proposed legislation aimed at attracting new investments and bringing back drug production deemed essential. Without making the UK an attractive destination for companies, Diane DiGangi Trench, who leads Sandoz Group AG in the UK, warns that the country will experience further shortages. This highlights the growing competition from the EU and the potential implications for the UK's medicine supply.